Treeline Biosciences
Latest round
- Series A
Last raised
- Aug 2025
Total raised
- $673M
Investors
- 14
About Treeline Biosciences
Treeline Biosciences, Inc.Founded in 2021 in Watertown, US, Treeline Biosciences, Inc. specializes in creating targeted therapies for serious diseases.Treeline Biosciences focuses on developing innovative therapeutics to address cancer and other serious diseases. Its pipeline includes diverse drug candidates that target specific disease mechanisms, offering potential solutions for various cancer forms. The internal development team collaborates with external contract research organizations (CROs) to enhance capabilities and scale operations. Additionally, revenue may arise from licensing agreements for proprietary drug candidates or partnerships with pharmaceutical companies for co-development of therapies. In August 2025, Treeline Biosciences, Inc. The company is focused on launching new therapeutics designed for cancer treatment, targeting specific global markets in North America and Europe by the end of 2025. These initiatives are expected to enhance research and development capabilities and facilitate strategic partnerships.
Who invested in Treeline Biosciences
14 investors across 3 rounds
See all investors in Treeline Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Treeline Biosciences
Who invested in Treeline Biosciences?
Treeline Biosciences has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Treeline Biosciences raised?
Treeline Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Treeline Biosciences last raise money?
Treeline Biosciences's most recent round on record is a Series A, in Aug 2025.
What does Treeline Biosciences do?
Treeline Biosciences is a biotechnology company.
Where is Treeline Biosciences headquartered?
Treeline Biosciences is headquartered in Watertown, US.
Which VCs invest in companies like Treeline Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Treeline Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Treeline Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.